Category: Alzheimer’s Disease

New Review Casts Doubt On Alzheimers Drugs But Is Controversial

There's a lot less than meets the eye to a recent Cochrane review that casts doubt on the efficacy of drugs for Alzheimer's disease.

/ April 22, 2026

Lithium and Alzheimer’s Disease

This is an interesting story, which has been all over the news so worthy of covering here. Alzheimer’s disease (AD), the major cause of dementia in humans, is a very complex disease. We have been studying it for decades, revealing numerous clues as to what kicks it off, what causes it to progress, and how to potentially treat it. This has lead...

/ August 13, 2025

FDA Advisory Committee Recommends approval of new Alzheimer’s drug Donanemab

If approved, donanemab would be the third FDA approved disease-modifying beta-amyloid treatment for Alzheimer’s disease.

/ June 23, 2024